Related content

Enhanced radiosensitivity of NSCLC cells by transducer of erbB2.1 (TOB1) through modulation of the MAPK/ERK pathway

By          

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2385-2391

Spandidos Publications

Access to resources Recommend Favorite

Dermatologic adverse events associated with afatinib: an oral ErbB family blocker

By Lacouture Mario E   Schadendorf Dirk   Chu Chia-Yu   Uttenreuther-Fischer Martina   Stammberger Uz   O'Brien Dennis   Hauschild Axel  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 6, 2013-06 ,pp. : 721-728

Informa Healthcare

Access to resources Recommend Favorite

Diarrhea associated with afatinib: an oral ErbB family blocker

By Yang James Chih-Hsin   Reguart Noemi   Barinoff Jana   Köhler Jens   Uttenreuther-Fischer Martina   Stammberger Uz   O'Brien Dennis   Wolf Jürgen   Cohen Ezra EW  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 6, 2013-06 ,pp. : 729-736

Informa Healthcare

Access to resources Recommend Favorite

ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology

By Jacobi Nico   Seeboeck Rita   Hofmann Elisabeth   Eger Andreas  

Cancers, Vol. 9, Iss. 4, 2017-04 ,pp. : 33-33

MDPI

Access to resources Recommend Favorite

Dual role of AP-2 in ErbB-2-induced mammary tumorigenesis

By Jäger Richard   Friedrichs Nicolaus   Heim Inge   Büttner Reinhard   Schorle Hubert  

Breast Cancer Research and Treatment, Vol. 90, Iss. 3, 2005-04 ,pp. : 273-280

Springer Publishing Company

Access to resources Recommend Favorite